Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Chabrol

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Journal of Medical Genetics|October 9, 2010
Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencingKaren Gaudon, Isabelle Pénisson-Besnier, Brigitte Chabrol, et al.
Annals of Neurology|June 23, 2015
CHCHD10 mutations are not a common cause of SMN1-negative type III/IV spinal motor atrophyGodelieve Morel, Cécile Rouzier, Annabelle Chaussenot, et al.
Brain : a Journal of Neurology|December 23, 2011
The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotypeCécile Rouzier, Sylvie Bannwarth, Annabelle Chaussenot, et al.
Orphanet Journal of Rare Diseases|February 22, 2022
Transition from child to adult health care for patients with lysosomal storage diseases in France: current status and priorities-the TENALYS study, a patient perspective surveyDelphine Genevaz, Armelle Arnoux, Catherine Marcel, et al.
Orphanet Journal of Rare Diseases|September 25, 2016
Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective studyMarie-Caroline Husson, Manuel Schiff, Alain Fouilhoux, et al.
Neurology|March 22, 2022
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French ExperienceAgathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Medecine Sciences : M/S|November 18, 2024
[Benefit of treatment with rituximab in autoimmune myasthenia gravis in children]Agathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Journal of Inherited Metabolic Disease|September 5, 2024
Long-term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan® Adult Maternal Paediatric European Registry multinational observational studyFrançois Feillet, Jean-Baptiste Arnoux, María Bueno Delgado, et al.
Orphanet Journal of Rare Diseases|July 21, 2023
Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective studyCécile Freihuber, Bahia Dahmani-Rabehi, Anaïs Brassier, et al.
Epilepsia|July 21, 2011
Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutationsMathieu Milh, Nathalie Villeneuve, Mondher Chouchane, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Journal of Medical Genetics|October 9, 2010
Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencingKaren Gaudon, Isabelle Pénisson-Besnier, Brigitte Chabrol, et al.
Annals of Neurology|June 23, 2015
CHCHD10 mutations are not a common cause of SMN1-negative type III/IV spinal motor atrophyGodelieve Morel, Cécile Rouzier, Annabelle Chaussenot, et al.
Brain : a Journal of Neurology|December 23, 2011
The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotypeCécile Rouzier, Sylvie Bannwarth, Annabelle Chaussenot, et al.
Orphanet Journal of Rare Diseases|February 22, 2022
Transition from child to adult health care for patients with lysosomal storage diseases in France: current status and priorities-the TENALYS study, a patient perspective surveyDelphine Genevaz, Armelle Arnoux, Catherine Marcel, et al.
Orphanet Journal of Rare Diseases|September 25, 2016
Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective studyMarie-Caroline Husson, Manuel Schiff, Alain Fouilhoux, et al.
Neurology|March 22, 2022
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French ExperienceAgathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Medecine Sciences : M/S|November 18, 2024
[Benefit of treatment with rituximab in autoimmune myasthenia gravis in children]Agathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Journal of Inherited Metabolic Disease|September 5, 2024
Long-term safety of sapropterin in paediatric and adult individuals with phenylalanine hydroxylase deficiency: Final results of the Kuvan® Adult Maternal Paediatric European Registry multinational observational studyFrançois Feillet, Jean-Baptiste Arnoux, María Bueno Delgado, et al.
Orphanet Journal of Rare Diseases|July 21, 2023
Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective studyCécile Freihuber, Bahia Dahmani-Rabehi, Anaïs Brassier, et al.
Epilepsia|July 21, 2011
Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutationsMathieu Milh, Nathalie Villeneuve, Mondher Chouchane, et al.
Pageof 15